Journal Article

Liver-directed lentiviral gene therapy corrects hemophilia A mice and achieves normal-range factor VIII activity in non-human primates

Naldini, Luigi, Mueller, Christian, Follenzi, Antonia, Annoni, Andrea, Cantore, Alessio, Russo, Fabio, Plati, Tiziana, Visigalli, Ilaria, Brombin, Chiara, Liu, Tongyao, Milani, Michela, Ayuso, Eduard, Drager, Douglas, Patarroyo-White, Susannah, Biffi, Mauro, Curto, Rosalia, Canepari, Cesare, Albertini, Paola

2022

Overview

Liver gene therapy with adeno-associated viral (AAV) vectors delivering clotting factor transgenes into hepatocytes has shown multiyear therapeutic benefit in adults with hemophilia. However, the mostly episomal nature of AAV vectors challenges their application to young pediatric patients. We developed lentiviral vectors, which integrate in the host cell genome, that achieve efficient liver gene transfer in mice, dogs and non-human primates, by intravenous delivery. Here we first compare engineered coagulation factor VIII transgenes and show that codon-usage optimization improved expression 10-20-fold in hemophilia A mice and that inclusion of an unstructured XTEN peptide, known to increase the half-life of the payload protein, provided an additional >10-fold increase in overall factor VIII output in mice and non-human primates. Stable nearly life-long normal and above-normal factor VIII activity was achieved in hemophilia A mouse models. Overall, we show long-term factor VIII activity and restoration of hemostasis, by lentiviral gene therapy to hemophilia A mice and normal-range factor VIII activity in non-human primate, paving the way for potential clinical application. “Lentiviral gene therapy to the liver establishes stable long-term normal to supra-normal coagulation factor VIII activity in mouse models of hemophilia A and in non-human primates, representing a potential new treatment option for people with hemophilia A.”.

• Publisher: Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
• Subject: 13/1 / 13/106 / 13/109 / 13/31 / 13/44 / 38/32 / 38/77 / 38/88 / 59 / 631/61/201 / 631/61/2300/1514 / 64/60 / 692/699/1541 / Animal models / Animals / Child / Clotting / Coagulation / Coagulation factor VIII / Coagulation factors / Dogs / Expression vectors / Factor VIII / Factor VIII - genetics / Factor VIII deficiency / Gene therapy / Genetic Therapy / Genetic Vectors / Genetic Vectors - genetics / Genomes / Hemophilia / Hemophilia A / Hemophilia A - genetics / Hemophilia A - therapy / Hemostasis / Hemostatics / Hepatocytes / HIV / Human health and pathology / Human immunodeficiency virus / Humanities and Social Sciences / Humans / Intravenous administration / Life Sciences / Liver / Liver - metabolism / Mice / Mouse devices / multidisciplinary / Optimization / Pediatrics / Polypeptides / Primates / Primates - genetics / Protein folding / Proteins / Science / Science (multidisciplinary) / Transgenes / Vectors (Biology)